Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 0.127\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCOc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
b. O=C(/C=C/C=C/c1ccccc1)CC1(O)C(=O)Nc2ccccc21
Answer: a. CCOc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
CCOc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
[4-amino-6-(4-ethoxyanilino)-1,3,5-triazin-2-yl]methyl morpholine-4-carbodithioate